JN Ingle

Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials.

Kathy S. Albain, S R Green, Allen S. Lichter et al. · Journal of Clinical Oncology · 1996 · 90 citations

Medicine, Oncology, Breast Oncology +15

Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

L.F. Porrata, JN Ingle, MR Litzow et al. · Bone Marrow Transplantation · 2001 · 88 citations

Medicine, Hematology, Oncology +15

The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.

David L. Ahmann, Daniel J. Schaid, Harry F. Bisel et al. · Journal of Clinical Oncology · 1987 · 64 citations

Medicine, Oncology, Pharmacology +10

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer.

Edward T. Creagan, S J Green, David L. Ahmann et al. · Journal of Clinical Oncology · 1984 · 37 citations

Medicine, Oncology, Pharmacology +14

Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.

Robert T. Eagan, Stephen Frytak, Edward T. Creagan et al. · PubMed · 1980 · 32 citations

Medicine, Oncology, Pharmacology +14